Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.0 - $9.95 $0 - $269,147
27,050 Added 56.62%
74,823 $0
Q3 2022

Oct 31, 2022

BUY
$8.57 - $11.57 $75,244 - $101,584
8,780 Added 22.52%
47,773 $425,000
Q2 2022

Aug 01, 2022

BUY
$8.84 - $11.64 $28,579 - $37,632
3,233 Added 9.04%
38,993 $389,000
Q1 2022

Apr 27, 2022

BUY
$10.07 - $11.93 $75,122 - $88,997
7,460 Added 26.36%
35,760 $414,000
Q4 2021

Jan 20, 2022

BUY
$7.95 - $11.24 $224,985 - $318,092
28,300 New
28,300 $314,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Lewis Capital Management, LLC Portfolio

Follow Lewis Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lewis Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lewis Capital Management, LLC with notifications on news.